Biotage AB (publ) (STO:BIOT)
Sweden
· Delayed Price · Currency is SEK 120.30
+2.40 (2.04%)
Feb 21, 2025, 5:29 PM CET
Biotage AB Revenue
In the year 2024, Biotage AB had annual revenue of 2.06B SEK with 10.42% growth. Biotage AB had revenue of 582.00M in the quarter ending December 31, 2024, a decrease of -9.49%.
Revenue
2.06B
Revenue Growth
+10.42%
P/S Ratio
4.68
Revenue / Employee
3.05M
Employees
674
Market Cap
9.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.06B | 194.00M | 10.42% |
| Dec 31, 2023 | 1.86B | 296.00M | 18.90% |
| Dec 31, 2022 | 1.57B | 334.00M | 27.11% |
| Dec 31, 2021 | 1.23B | 140.00M | 12.82% |
| Dec 31, 2020 | 1.09B | -9.37M | -0.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |